Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Prasugrel suppresses the early rise of sCD40 ligand levels following PCI compared to clopidogrel: a JUMBO-TIMI 26 substudy

Prasugrel suppresses the early rise of sCD40 ligand levels following PCI compared to clopidogrel: a JUMBO-TIMI 26 substudy. Circulation. 2005; 112:II-432.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.